Altamira Therapeutics Ltd. Cash Flows From Used In Operating Activities
Altamira Therapeutics Ltd. (CYTOF) reported Cash Flows From Used In Operating Activities of -$1.38 million for the 6-month period ending 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Cash Flow › Operating Activities
ifrs-full:CashFlowsFromUsedInOperatingActivities · last filed 2025-08-29
CHF
| Period end | Cash Flows From Used In Operating Activities 12 month |
|---|---|
| 2018-12-31 | -13.23M CHF 20-F · filed 2019-03-14 |
| 2017-12-31 | -24.28M CHF 20-F · filed 2019-03-14 |
| 2016-12-31 | -29.45M CHF 20-F · filed 2019-03-14 |
| 2015-12-31 | -28.73M CHF 20-F · filed 2018-03-22 |
USD
| Period end | Cash Flows From Used In Operating Activities 6 month | Cash Flows From Used In Operating Activities 12 month |
|---|---|---|
| 2025-06-30 | -$1.38M 6-K · filed 2025-08-29 | |
| 2024-12-31 | -$6.11M 20-F · filed 2025-04-30 | |
| 2024-06-30 | -$3.20M 6-K · filed 2025-08-29 | |
| 2023-12-31 | -$12.81M 20-F · filed 2025-04-30 | |
| 2022-12-31 | -$9.09M 20-F · filed 2025-04-30 |